These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32881078)

  • 21. A 25 mg rectal dose of diclofenac for prevention of post-ERCP pancreatitis in elderly patients.
    Maeda N; Higashimori A; Nakatani M; Mizuno Y; Nakamura Y; Ikeda D; Maruyama H; Morimoto K; Fukuda T; Watanabe T; Fujiwara Y
    Scand J Gastroenterol; 2021 Sep; 56(9):1109-1116. PubMed ID: 34328810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study.
    Yoshihara T; Horimoto M; Kitamura T; Osugi N; Ikezoe T; Kotani K; Sanada T; Higashi C; Yamaguchi D; Ota M; Mizuno T; Gotoh Y; Okuda Y; Suzuki K
    BMJ Open; 2015 Mar; 5(3):e006950. PubMed ID: 25795692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
    Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units.
    Rainio M; Lindström O; Udd M; Louhimo J; Kylänpää L
    J Gastrointest Surg; 2017 Aug; 21(8):1270-1277. PubMed ID: 28374181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
    Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
    J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
    Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
    United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
    Li X; Tao LP; Wang CH
    World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
    Cheon YK
    Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydration with Lactated Ringer's solution combined with rectal diclofenac in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography.
    Del Olmo Martínez ML; Velayos Jiménez B; Almaraz-Gómez A
    Gastroenterol Hepatol; 2021 Jan; 44(1):20-26. PubMed ID: 32674877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
    Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
    Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NSAIDs do not reduce severity among post-ERCP pancreatitis patients.
    El Kurdi B; Imam Z; Abonofal A; Babar S; Shah P; Pannala R; Papachristou G; Echavarria J; Pisipati S; Jahangir S; Rajalingamgari P; Chang YH; Singh VP
    Pancreatology; 2024 Feb; 24(1):14-23. PubMed ID: 37981523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a Danish cohort study.
    Leerhøy B; Nordholm-Carstensen A; Novovic S; Hansen MB; Jørgensen LN
    Pancreas; 2014 Nov; 43(8):1286-90. PubMed ID: 25003219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
    Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
    Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.